VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
STRO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
STROSutro Biopharma, Inc.
$8.50$82M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksSTROFinancials

Sutro Biopharma, Inc. (STRO) Income Statement

10Y historyFree accessUpdated daily

Sutro Biopharma, Inc. (STRO) annual income statement — 10-year revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

STRO Income Statement

Annual statement

STRO Income Statement

Sutro Biopharma, Inc. (STRO) annual income statement — 10-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16
Sales/Revenue45.11M102.48M62.04M153.73M67.77M61.88M42.72M42.74M38.42M51.74M59.73M
Revenue Growth %-57.3%65.18%-59.64%126.84%9.52%44.84%-0.03%11.24%-25.75%-13.38%-
Cost of Goods Sold2.52M7.32M7.22M6.82M8.29M9.77M76.96M054.26M51.9M43.55M
COGS % of Revenue-7.15%11.63%4.43%12.23%15.79%180.14%-141.24%100.3%72.91%
Gross Profit42.59M95.16M54.83M146.91M59.48M52.11M-34.24M42.74M-15.84M-156K16.18M
Gross Margin %94.41%92.85%88.37%95.57%87.77%84.21%-80.14%100%-41.24%-0.3%27.09%
Gross Profit Growth %-73.57%-62.68%146.98%14.16%252.19%-180.12%369.75%-10055.77%-100.96%-
Operating Expenses157.68M200.11M293.28M236.19M188.43M150.63M36.82M98.2M75.64M71.01M58.37M
OpEx % of Revenue-195.26%472.7%153.64%278.03%243.42%86.18%229.79%196.89%137.25%97.72%
Selling, General & Admin31.62M41.02M48.45M62.58M59.54M56M36.82M32.59M21.38M16.37M14.82M
SG&A % of Revenue-40.02%78.1%40.71%87.86%90.5%86.18%76.26%55.65%31.65%24.81%
Research & Development128.39M166.42M252.04M180.43M137.17M104.4M76.96M65.61M54.26M54.64M43.55M
R&D % of Revenue-162.38%406.24%117.36%202.4%168.71%180.14%153.53%141.24%105.6%72.91%
Other Operating Expenses-1.8M-7.32M-7.22M-6.82M-8.29M-9.77M-76.96M01.91M-77K87K
Operating Income-115.11M-104.95M-238.45M-89.28M-128.94M-98.52M-71.06M-55.47M-37.22M-19.27M1.36M
Operating Margin %-255.2%-102.41%-384.34%-58.07%-190.26%-159.22%-166.32%-129.79%-96.89%-37.25%2.28%
Operating Income Growth %-55.99%-167.09%30.76%-30.87%-38.65%-28.1%-49.02%-93.15%-1512.9%-
EBITDA-109.71M-97.63M-231.24M-82.46M-123.25M-93.68M-66.76M-50.69M-32.68M-14.28M7.03M
EBITDA Margin %-243.22%-95.26%-372.7%-53.64%-181.86%-151.39%-156.27%-118.61%-85.07%-27.6%11.76%
EBITDA Growth %38.37%57.78%-180.41%33.1%-31.57%-40.32%-31.7%-55.09%-128.85%-303.27%-
D&A (Non-Cash Add-back)5.41M7.32M7.22M6.82M5.69M4.84M4.3M4.78M4.54M4.99M5.66M
EBIT-115.55M-152.97M-187.67M-74.73M-113.36M-102.4M-28.05M-51.39M-37.22M-19.08M1.36M
Net Interest Income-33.45M-28.96M13.36M-9.24M109K-2.56M-2.47M-276K16K-416K251K
Interest Income6.36M9.25M44.42M14.51M3.46M577K1.51M4.07M1.62M273K251K
Interest Expense39.81M38.21M31.07M23.75M3.35M3.14M3.97M4.35M1.6M689K0
Other Income/Expense-40.25M-86.23M13.36M677K12.24M-7.01M38.93M-276K1.91M-416K338K
Pretax Income-155.36M-191.18M-225.1M-88.6M-116.7M-105.54M-32.13M-55.74M-35.32M-19.69M1.7M
Pretax Margin %-344.43%-186.55%-362.81%-57.63%-172.2%-170.55%-75.2%-130.44%-91.93%-38.05%2.85%
Income Tax-96K-93K2.36M18.19M2.5M000000
Effective Tax Rate %0.06%0.05%-1.05%-20.53%-2.14%0%0%0%0%0%0%
Net Income-155.27M-191.09M-227.46M-106.79M-119.2M-105.54M-32.13M-55.74M-35.32M-19.69M1.7M
Net Margin %-344.22%-186.45%-366.62%-69.47%-175.89%-170.55%-75.2%-130.44%-91.93%-38.05%2.85%
Net Income Growth %28.37%15.99%-112.99%10.41%-12.95%-228.49%42.37%-57.84%-79.38%-1256.76%-
Net Income (Continuing)-155.27M-191.09M-227.46M-106.79M-119.2M-105.54M-32.13M-55.74M-35.32M-19.69M1.7M
Discontinued Operations00000000000
Minority Interest00000000000
EPS (Diluted)-9.36-22.49-29.60-17.80-23.50-22.90-9.90-24.30-15.40-28.1038.60
EPS Growth %51.46%24.02%-66.29%24.26%-2.62%-131.31%59.26%-57.79%45.2%-172.8%-
EPS (Basic)--22.49-29.60-17.80-23.50-22.90-9.90-24.30-15.50-28.1038.60
Diluted Shares Outstanding16.58M8.5M7.68M6.02M5.07M4.61M3.26M2.3M2.29M699.74K44.12K
Basic Shares Outstanding16.58M8.5M7.68M6.02M5.07M4.61M3.26M2.3M2.29M699.74K44.12K
Dividend Payout Ratio-----------

STRO — Frequently Asked Questions

Quick answers to the most common questions about buying STRO stock.

What was Sutro Biopharma, Inc.'s (STRO) revenue in 2025?

For fiscal year 2025, Sutro Biopharma, Inc. (STRO) reported total revenue of $102.5M. This represents a 71.6% increase compared to $59.7M in 2016.

Is Sutro Biopharma, Inc. (STRO) profitable?

Sutro Biopharma, Inc. (STRO) reported a net loss of $191.1M for the fiscal year ending 2025.

What is Sutro Biopharma, Inc.'s operating profit margin?

Sutro Biopharma, Inc. (STRO) reported an operating income of $-105.0M, resulting in an operating profit margin of -102.4%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Sutro Biopharma, Inc.'s gross profit and gross margin?

Sutro Biopharma, Inc. (STRO) generated $95.2M in gross profit for the year, representing a gross profit margin of 92.9%. This demonstrates the company's core pricing power and production efficiency.